News Room

Revenue and Profit Maintain Steady Growth;

Enhancing Integrated Healthcare, Preventive Care and Digitalisation

 

(Hong Kong —— September 29,2026) Human Health Holdings Limited (“Human Health” or the “Company”, together with its subsidiaries, the “Group”; stock code: 1419), a leading private integrated healthcare service provider in Hong Kong, announces  its consolidated annual results for the year ended 30 June 2026 (the “FY2026”).

 

Facing challenges including cautious consumer sentiment, rising healthcare costs and competition from cross-boundary medical services, the Group maintained steady growth in the FY2026. During the year, Human Health continued to enhance service quality and operational efficiency, expand specialist and preventive healthcare services, advance the integration of its dental services, and strengthen synergies between its medical network and digital systems, further consolidating its integrated healthcare services platform.

 

Financial Performance

 

• Steady Revenue Growth: The Group's revenue for FY2026 was approximately HK$671.7 million, representing an increase of approximately 4.2% as compared with HK$644.4 million for FY2025. This growth was mainly driven by the increased revenue from general practice services and dental services.

 

• Sustained Profit Growth: The profit attributable to owners of the Company for FY2026 was approximately HK$27.1 million, representing an increase of approximately HK$0.8 million or 3.0% as compared to approximately HK$26.3 million for FY2025.

 

• Earnings Per Share: Basic earnings per share for FY2026 amounted to approximately HK7.1 cents (FY2025: approximately HK6.9 cents).

 

• Dividend: The Board proposed declaration of final dividend of 1 cents for FY2026 (FY2025: HK3.0 cents).

 

Business Segment Performance

1. General Practice Segment

• Revenue reached HK$ 418.4 million, recorded a year- on- year growth of approximately 1.8%.
• The growth was mainly attributed to the increase in patient visits and the average spending per visit of the general practice service.
• The Group partnered with reputable international bank to open a new medical centre in Central while selected existing centres underwent renovation to improve the service environment and patient experience..
• The Group also extended telemedicine consultation services to provide patients with more flexible medical options outside regular clinic hours. It also continued to promote weight management, metabolic health, vaccination and outreach services in response to market demand for preventive care.

 

2. Specialties Segment

• Revenue reached HK$ 163.1 million, recorded a slight decrease of approximately 1.7%,  mainly due to the decrease spending per patient visit, although it was partly offset by the increase in patient visits of the specialties service.
• The segment's gross profit margin increased from approximately 29.6% last year to approximately 32.3%, reflecting continuous improvement in cost management and service mix.
• During the year, the Group expanded its pool of medical specialists, including the engagement of additional professionals in otorhinolaryngology and dermatology.
• POLYEYE continued to offer a range of eye care services to patients across different age groups; Healthy Square H2 in Star House also provided additional specialists and expanded its scope of services to improve facility utilisation and integrated service capabilities.

 

3. Dental Segment

• Revenue reached HK$ 90.2 million, recorded a significant year- on- year growth of approximately 33.1%.
• The growth was primarily due to the contribution from Monarch Dental Clinic Limited (“Monarch Dental”) following its acquisition in February 2025, including theincrease in patient visits and average spending per visit.
• During the year, the Group continued to advance the integration of Monarch Dental service into our existing healthcare services platform, including practitioner engagement, alignment of service standards and administrative workflows, and closer operational coordination across the enlarged platform.
• Gross profit margin increased from approximately 42.9% to approximately 43.6%, reflecting continuous improvement in cost management and service mix.

 

Enhanced Healthcare and Wellness Offering at Healthy Square H2
Healthy Square H2 in Tsim Sha Tsui continued act as an integrated medical and wellness hub, bringing together specialties, dental, health management, day procedure, community pharmacy and retail services at a single location, enables customers to access a wider spectrum of healthcare and wellness services and creates greater scope for interaction among the Group’s different service platforms. IMPACT health management centre, the Group’s dedicated health management centre at H2, offers health assessment, diagnostic and preventive services tailored to different health needs. The centre also raised customers' awareness of disease prevention, lifestyle management and appropriate follow-up through health consultations and educational seminars.

 

Integrated Digital Operations, Enhancing Service Efficiency

The Group further integrated its digital systems into daily operations to improve patient experience, enhance service efficiency and strengthen collaboration among its different service points. The queuing system, including a dedicated priority arrangement for elderly patients, was in operation at most medical centres, contributing to smoother patient flow, shorter waiting times and more predictable service turnaround. The omnichannel messaging platform was also fully deployed across the network to support appointment booking, enquiry management and customer communication; the integrated clinic operating system was in use at most medical centres helping simplification of workflows while improving coordination across service points. During the year, the Group successfully connected to the Electronic Health System (“eHealth”) and accredited for its capability to upload electronic health records into eHealth automatically (bronze-level recognition), laying the foundation for enhanced cross-platform healthcare collaboration in the future.

 

Mr. Chan Kin Ping, SBS, JP said “Facing changing consumption patterns, rising costs and cross-boundary medical services competition, the Group still recorded a steady growth in FY2026, reflecting the resilient development of its integrated healthcare platform. During the year, the dental segment performed exceptionally well, while general practice and specialities services remained stable. We also continued to expand preventive care, optimise digital operations and enhance cross-platform collaboration. Looking ahead, the Group will prudently allocate resources, further strengthen synergies among its various medical services, improve service quality and accessibility, and leverage digital technology to enhance operating efficiency and improve patient experience.”

 

Business Outlook

Looking ahead, although Hong Kong's private healthcare market continues to evolve amid changing consumer preferences, cross-boundary competition, persistent cost pressures, ageing population, greater health awareness and increasing attention to primary and preventive care are expected to underpin healthcare demand over the longer term. The Group will adhere to a prudent and disciplined approach, allocate resources according to market needs and capture suitable growth opportunities. The Group will pursue demand-driven network expansion at suitable locations and broaden telemedicine services and expand specialties capacity through the engagement of additional professionals and a wider service offering at Healthy Square H2. In the dental business, the Group will continue to consolidate the dental platform by aligning service standards and improving operational coordination across the network, fully leverage the synergies of the expanded dental platform.

 

At the same time, the Group will strengthen prevention, diagnosis and health management services, the wider day procedure offering will improve facility utilisation and enhance the integrated healthcare experience. In terms of digitalisation, the omnichannel messaging platform, queuing system, integrated clinic operating system and eHealth connectivity will be refined to streamline appointment handling and customer communication, facilitate closer coordination and improve information flow across service points. In addition, Human Health Charity Limited will broaden the Group’s community engagement through a more dedicated platform for health promotion and social support. With the government’s presentation of the first Five-Years Plan, the Group will support to deepen the reformation of the healthcare system, continue to invest resources in nurturing professional healthcare talent and promote referrals and synergies among general practice, specialties, dental, diagnostics, health management, community pharmacy and day procedure services and create sustainable long-term value for patients, shareholders and other stakeholders through providing high quality and efficient healthcare services.

 

- END –

 

About Human Health Holdings Limited

Human Health, listed on the Main Board of the Hong Kong Stock Exchange (Stock Code: 1419), is one of the largest medical groups in Hong Kong. Having been serving the community since 1997, the Group operates more than 60 medical centres, with more than 800 professional team members and staff. With an aim to ”Elevate Your Health Values, Elevate Your Life", Human Health provides comprehensive medical services network including general practice, specialties, dental, eye care, physiotherapy, outreach, rehabilitation and case management, diagnostics & imaging, day procedure and endoscopy, medical aesthetics, Chinese medicine, health and wellness services, and the sale of healthcare related products and services, providing the public with professional and person-centered medical and wellness services.

 

Media Enquiries:

China Times Corporate Advisory Limited

Destiny Cheng

Tel: (852) 6220 0861

Email: pr@ctimes.hk

Fax: (852) 3428 3012